Funded Biotechnology Startups in Calgary
Among the 10 most recent biotechnology rounds shown, the largest disclosed amount is Oncolytics Biotech’s $20M (2025-04-10), and it stands well above the n…
Among the 10 most recent biotechnology rounds shown, the largest disclosed amount is Oncolytics Biotech’s $20M (2025-04-10), and it stands well above the next-highest disclosed rounds such as FluroTech’s $16M (2024-05-01) and Xortx Therapeutics’s $5M (2026-05-14). Most other disclosed amounts cluster between $150K and $6M, with Marvel Biosciences at $360K (2026-04-08), Resverlogix at $2M (2026-05-19), and Psygen Labs at $6M (2021-08-05).
The geography is heavily Calgary-centered: 8 of 10 entries list Calgary, Alberta (with one additional Ontario entry, Zamplo in 2025-01-03). Temporally, rounds span 2021-08-05 (Psygen Labs, $6M) through the most recent 2026-05-19 (Resverlogix, $2M). Stage/disclosure is also concentrated: 5 of 10 rounds are “Series Unknown,” and 3 of 10 amounts are “undisclosed” (NanoTess Inc., 2026-04-27; Syantra, 2025-02-26; Qualisure Diagnostics, 2022-09-13).
Most recent rounds
10 shownRelated listings
Frequently asked
Which disclosed round is the size outlier, and how does it compare to the next-largest disclosed amount?
Oncolytics Biotech’s disclosed $20M on 2025-04-10 is the clearest outlier; the next-largest disclosed entries are FluroTech at $16M (2024-05-01) and then Xortx Therapeutics at $5M (2026-05-14).
Do the most recent rounds cluster in a narrow time window?
Yes. Five of the 10 rows fall in 2026: Resverlogix ($2M, 2026-05-19), Xortx Therapeutics ($5M, 2026-05-14), NanoTess Inc. (undisclosed, 2026-04-27), and Marvel Biosciences ($360K, 2026-04-08), plus the next earlier 2025-04-10 gap to Oncolytics Biotech ($20M).
Is Calgary over-represented versus other geographies in this list?
Calgary dominates: 8 of 10 entries list Calgary, Alberta (including Resverlogix on 2026-05-19 through Qualisure Diagnostics in 2022-09-13). The only other geography shown is Zamplo in Calgary, Ontario (seed, $150K on 2025-01-03).
What does the stage/disclosure mix look like among these recent biotechnology rounds?
“Series Unknown” appears in 5 of 10 rows (e.g., Resverlogix on 2026-05-19 and FluroTech on 2024-05-01). Separately, 3 of 10 amounts are undisclosed (NanoTess Inc., 2026-04-27; Syantra, 2025-02-26; Qualisure Diagnostics, 2022-09-13).
Which entries are potential follow-up candidates because their disclosed amounts sit at the low end?
Several are clustered near sub-$1M levels: Marvel Biosciences at $360K (2026-04-08) and Zamplo at $150K (2025-01-03). Others are still low but higher, like Resverlogix at $2M (2026-05-19) versus the larger disclosed $6M–$20M rounds (Psygen Labs $6M in 2021-08-05; FluroTech $16M in 2024-05-01; Oncolytics Biotech $20M in 2025-04-10).
If a reviewer wants to understand stage variety, where are the clearly specified stages in this set?
Beyond “Series Unknown,” the explicitly shown stages include Seed (Zamplo: $150K on 2025-01-03; Qualisure Diagnostics: undisclosed on 2022-09-13) and Debt Financing (Psygen Labs: $6M on 2021-08-05). These specified-stage entries are fewer than the “Series Unknown” rows (2 vs. 5).
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.